*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
C6211 - Malignant neoplasm of descended right testis - as a primary diagnosis code | C6211 - Malignant neoplasm of descended right testis - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 7.03 | |
Readmission Rate (%) | 52.31 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|
Total Hospitalizations at DRG | 1,428 |
Total Hospitalizations with ICD C6211 - Malignant neoplasm of descended right testis | 12 |
DRG Share of Total Hospitalizations | 0.0 |
% of Total ICD C6211 - Malignant neoplasm of descended right testis in DRG | 75.0 |
Avg LOS at DRG | 7.26 |
Avg LOS with ICD C6211 - Malignant neoplasm of descended right testis | 7.83 |
Readmission Rate at DRG | 20.22 |
Readmission Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA |
Unplanned Readmission Rate at DRG | 12.19 |
Unplanned Readmission Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA |
Total Medicare payments at DRG | $20,276,943 |
Total Medicare payments with ICD C6211 - Malignant neoplasm of descended right testis | $193,249 |
Total Medicare payment per Day at DRG | $1,957 |
Total Medicare payment per Day with ICD C6211 - Malignant neoplasm of descended right testis | $2,056 |
Total Medicare payment per Hospitalization at DRG | $14,200 |
Total Medicare payment per Hospitalization with ICD C6211 - Malignant neoplasm of descended right testis | $16,104 |
Total Medicare Charges at DRG | $101,741,263 |
Total Medicare Charges with ICD C6211 - Malignant neoplasm of descended right testis | $999,630 |
Avg Charges at DRG | $71,247 |
Avg Charges with ICD C6211 - Malignant neoplasm of descended right testis | $83,303 |
Mortality Rate at DRG | NA |
Mortality Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA |
SNF Discharge Rate at DRG | 22.13 |
SNF Discharge Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA |
Home Discharge Rate at DRG | 47.97 |
Home Discharge Rate with ICD C6211 - Malignant neoplasm of descended right testis | 100.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|
Total Hospitalizations at DRG | 45,065 | |
Total Hospitalizations with ICD C6211 - Malignant neoplasm of descended right testis | 13 | |
DRG Share of Total Hospitalizations | 0.14 | |
% of Total ICD C6211 - Malignant neoplasm of descended right testis in DRG | 18.57 | |
Avg LOS at DRG | 4.03 | |
Avg LOS with ICD C6211 - Malignant neoplasm of descended right testis | 4.69 | |
Readmission Rate at DRG | 66.75 | |
Readmission Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA | |
Unplanned Readmission Rate at DRG | 10.94 | |
Unplanned Readmission Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA | |
Total Medicare payments at DRG | $438,494,977 | |
Total Medicare payments with ICD C6211 - Malignant neoplasm of descended right testis | $158,036 | |
Total Medicare payment per Day at DRG | $2,416 | |
Total Medicare payment per Day with ICD C6211 - Malignant neoplasm of descended right testis | $2,591 | |
Total Medicare payment per Hospitalization at DRG | $9,730 | |
Total Medicare payment per Hospitalization with ICD C6211 - Malignant neoplasm of descended right testis | $12,157 | |
Total Medicare Charges at DRG | $2,145,591,374 | |
Total Medicare Charges with ICD C6211 - Malignant neoplasm of descended right testis | $324,441 | |
Avg Charges at DRG | $47,611 | |
Avg Charges with ICD C6211 - Malignant neoplasm of descended right testis | $24,957 | |
Mortality Rate at DRG | 0.08 | |
Mortality Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA | |
SNF Discharge Rate at DRG | 4.35 | |
SNF Discharge Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA | |
Home Discharge Rate at DRG | 81.76 | |
Home Discharge Rate with ICD C6211 - Malignant neoplasm of descended right testis | NA |